United States · Platforms & data · MarketBeat
What CapsoVision (CV) Said on Its Q3 Earnings Call
Detailed summary
CapsoVision (NASDAQ:CV) reported modest third-quarter revenue growth as it prepared to introduce its artificial intelligence-assisted small bowel imaging software in the U.S. and complete a regulatory submission for its colon capsule. Revenue was $3.6 million, up 1% from the third quarter of 2025,
MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketbeat.com)
